We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

168 hedge funds and large institutions have $1.17B invested in Select Medical in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 78 increasing their positions, 43 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 43

48% more call options, than puts

Call options by funds: $906K | Put options by funds: $612K

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

7.73% more ownership

Funds ownership: 130.37%138.1% (+7.7%)

2% more funds holding

Funds holding: 165168 (+3)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

19% less capital invested

Capital invested by funds: $1.45B → $1.17B (-$272M)

Holders
168
Holders Change
+3
Holders Change %
+1.82%
% of All Funds
4.87%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
26
Increased
78
Reduced
43
Closed
22
Calls
$906K
Puts
$612K
Net Calls
+$294K
Net Calls Change
-$1.43M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
51
Charles Schwab
California
$3.7M +$610K +79,008 +16%
Connor, Clark & Lunn Investment Management (CC&L)
52
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.67M +$3.13M +405,536 +253%
GAM
53
Gotham Asset Management
New York
$3.56M -$247K -31,936 -5%
Asset Management One
54
Asset Management One
Japan
$3.16M
PPA
55
Parametric Portfolio Associates
Washington
$3.13M +$1.29M +166,413 +53%
Barclays
56
Barclays
United Kingdom
$2.96M +$3.08M +399,083 +679%
U
57
UBS
Switzerland
$2.9M +$2.31M +298,545 +200%
Deutsche Bank
58
Deutsche Bank
Germany
$2.85M +$2.77M +358,111 +438%
BIM
59
Bogle Investment Management
Massachusetts
$2.78M -$3.58M -463,347 -52%
BIM
60
BlackRock Investment Management
Delaware
$2.62M +$28.5K +3,688 +0.9%
CS
61
Comerica Securities
Michigan
$2.49M +$2.96M +383,554 New
Jacobs Levy Equity Management
62
Jacobs Levy Equity Management
New Jersey
$2.41M -$59.8K -7,740 -2%
SIM
63
Spark Investment Management
New York
$2.28M -$555K -71,828 -17%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$2.21M +$2.16M +279,724 +451%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$2.08M +$349K +45,171 +16%
CS
66
Credit Suisse
Switzerland
$2.02M -$69.4K -8,985 -3%
CAM
67
ClariVest Asset Management
California
$2M -$734 -95 -0%
HI
68
HBK Investments
Texas
$1.98M +$1.27M +164,998 +118%
EA
69
Evanston Advisors
Illinois
$1.89M +$375K +48,506 +20%
ZCM
70
Zebra Capital Management
Connecticut
$1.89M +$78.4K +10,149 +4%
AllianceBernstein
71
AllianceBernstein
Tennessee
$1.85M
NFA
72
Nationwide Fund Advisors
Ohio
$1.82M +$7.15K +926 +0.3%
SAM
73
Shell Asset Management
Netherlands
$1.78M +$198K +25,678 +10%
Goldman Sachs
74
Goldman Sachs
New York
$1.74M +$2.66K +345 +0.1%
LG
75
Leuthold Group
Minnesota
$1.66M +$1.98M +256,495 New

SEM Hedge Fund Activity: Q3 2014 in Review

168 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2014, worth a combined $1.17B — down 19% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new SEM positions and 22 closed out — a net gain of 4 holders — while 78 added to existing stakes and 43 trimmed.

The largest buyer was Vanguard Group, adding an estimated $10.9M. The largest seller was BlackRock Institutional Trust, cutting an estimated $14.4M.

  • 168 institutional investors held Select Medical (SEM) as of Q3 2014, up from 165 in Q2 2014.
  • Funds reported $1.17B of Select Medical stock for Q3 2014, down 19% quarter-over-quarter.
  • 26 funds opened new Select Medical positions in Q3 2014 and 22 closed out, a net change of +4 holders.
  • The largest Select Medical buyer in Q3 2014 was Vanguard Group, an estimated $10.9M added.
  • The largest Select Medical seller in Q3 2014 was BlackRock Institutional Trust, an estimated $14.4M sold.

Based on aggregated 13F filings for Q3 2014.